Come up with a name for your new list and we'll add to it:
ZS Pharma raised a round of funding on July 10, 2012. Investors include
Devon Park Bioventures.
ZS Pharma is a specialty pharmaceutical company focused on the development and commercialization of oral sorbent technology. The company's lead therapeutic candidate, ZS-9, is a novel treatment for hy…